Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/31993
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SALOMAO, R. | |
dc.contributor.author | FERREIRA, B. L. | |
dc.contributor.author | SALOMAO, M. C. | |
dc.contributor.author | SANTOS, S. S. | |
dc.contributor.author | AZEVEDO, L. C. P. | |
dc.contributor.author | BRUNIALTI, M. K. C. | |
dc.date.accessioned | 2019-05-30T13:49:48Z | |
dc.date.available | 2019-05-30T13:49:48Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.52, n.4, article ID e8595, 14p, 2019 | |
dc.identifier.issn | 0100-879X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/31993 | |
dc.description.abstract | Sepsis remains a major cause of morbidity and mortality worldwide, with increased burden in low-and middle-resource settings. The role of the inflammatory response in the pathogenesis of the syndrome has supported the modern concept of sepsis. Nevertheless, a definition of sepsis and the criteria for its recognition is a continuous process, which reflects the growing knowledge of its mechanisms and the success and failure of diagnostic and therapeutic interventions. Here we review the evolving concepts of sepsis, from the ""systemic inflammatory response syndrome triggered by infection'' (Sepsis-1) to ""a severe, potentially fatal, organic dysfunction caused by an inadequate or dysregulated host response to infection'' (Sepsis-3). We focused in the pathophysiology behind the concept and the criteria for recognition and diagnosis of sepsis. A major challenge in evaluating the host response in sepsis is to characterize what is protective and what is harmful, and we discuss that, at least in part, the apparent dysregulated host response may be an effort to adapt to a hostile environment. The new criteria for recognition and diagnosis of sepsis were derived from robust databases, restricted, however, to developed countries. Since then, the criteria have been supported in different clinical settings and in different economic and epidemiological contexts, but still raise discussion regarding their use for the identification versus the prognostication of the septic patient. Clinicians should not be restricted to definition criteria when evaluating patients with infection and should wisely use the broad array of information obtained by rigorous clinical observation. | eng |
dc.description.sponsorship | FAPESP [2017/21052-0] | |
dc.description.sponsorship | CNPq [305685/2011-2] | |
dc.language.iso | eng | |
dc.publisher | ASSOC BRAS DIVULG CIENTIFICA | eng |
dc.relation.ispartof | Brazilian Journal of Medical and Biological Research | |
dc.rights | openAccess | eng |
dc.subject | Sepsis-3 | eng |
dc.subject | Inflammatory response | eng |
dc.subject | Immunometabolism | eng |
dc.subject | qSOFA | eng |
dc.subject | SOFA | eng |
dc.subject.other | international consensus definitions | eng |
dc.subject.other | in-hospital mortality | eng |
dc.subject.other | septic shock | eng |
dc.subject.other | cytokine production | eng |
dc.subject.other | human monocytes | eng |
dc.subject.other | mitochondrial dysfunction | eng |
dc.subject.other | staphylococcus-aureus | eng |
dc.subject.other | prognostic accuracy | eng |
dc.subject.other | clinical-criteria | eng |
dc.subject.other | medical progress | eng |
dc.title | Sepsis: evolving concepts and challenges | eng |
dc.type | article | eng |
dc.rights.holder | Copyright ASSOC BRAS DIVULG CIENTIFICA | eng |
dc.identifier.doi | 10.1590/1414-431X20198595 | |
dc.identifier.pmid | 30994733 | |
dc.subject.wos | Biology | eng |
dc.subject.wos | Medicine, Research & Experimental | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | SALOMAO, R.:Univ Fed Sao Paulo, Disciplina Infectol, Escola Paulista Med, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | FERREIRA, B. L.:Univ Fed Sao Paulo, Disciplina Infectol, Escola Paulista Med, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SANTOS, S. S.:Univ Fed Sao Paulo, Disciplina Infectol, Escola Paulista Med, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | AZEVEDO, L. C. P.:Hosp Sirio Libanes, Unidade Terapia Intens, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | BRUNIALTI, M. K. C.:Univ Fed Sao Paulo, Disciplina Infectol, Escola Paulista Med, Sao Paulo, SP, Brazil | |
hcfmusp.description.articlenumber | e8595 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 52 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000464667000001 | |
hcfmusp.origem.id | SCIELO:S0100-879X2019000400301 | |
hcfmusp.origem.id | 2-s2.0-85064993630 | |
hcfmusp.publisher.city | RIBEIRAO PRETO | eng |
hcfmusp.publisher.country | BRAZIL | eng |
hcfmusp.relation.reference | Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b | eng |
hcfmusp.relation.reference | Alves-Januzzi AB, 2017, CYTOM PART B-CLIN CY, V92, P192, DOI 10.1002/cyto.b.21321 | eng |
hcfmusp.relation.reference | Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623 | eng |
hcfmusp.relation.reference | [Anonymous], 2013, ANTIBIOTIC RESISTANC | eng |
hcfmusp.relation.reference | Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748 | eng |
hcfmusp.relation.reference | Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001 | eng |
hcfmusp.relation.reference | Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009 | eng |
hcfmusp.relation.reference | BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457 | eng |
hcfmusp.relation.reference | BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644 | eng |
hcfmusp.relation.reference | Bone RC, 1996, CLIN CHEST MED, V17, P175, DOI 10.1016/S0272-5231(05)70307-5 | eng |
hcfmusp.relation.reference | Bozza FA, 2013, SHOCK, V39, P10, DOI 10.1097/SHK.0b013e31828fade1 | eng |
hcfmusp.relation.reference | Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X | eng |
hcfmusp.relation.reference | Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29 | eng |
hcfmusp.relation.reference | Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985 | eng |
hcfmusp.relation.reference | Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC | eng |
hcfmusp.relation.reference | Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742 | eng |
hcfmusp.relation.reference | Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055 | eng |
hcfmusp.relation.reference | Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398 | eng |
hcfmusp.relation.reference | Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684 | eng |
hcfmusp.relation.reference | Costa RT, 2018, J CRIT CARE, V45, P52, DOI 10.1016/j.jcrc.2017.12.024 | eng |
hcfmusp.relation.reference | Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1 | eng |
hcfmusp.relation.reference | del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350 | eng |
hcfmusp.relation.reference | Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af | eng |
hcfmusp.relation.reference | DeMerle KM, 2017, CRIT CARE MED, V45, P1702, DOI 10.1097/CCM.0000000000002626 | eng |
hcfmusp.relation.reference | Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC | eng |
hcfmusp.relation.reference | Esquerdo KF, 2017, CLIN EXP IMMUNOL, V189, P232, DOI 10.1111/cei.12971 | eng |
hcfmusp.relation.reference | Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-4180C | eng |
hcfmusp.relation.reference | Fensterheim BA, 2018, J IMMUNOL, V200, P3777, DOI 10.4049/jimmunol.1800085 | eng |
hcfmusp.relation.reference | Fensterheim BA, 2017, J IMMUNOL, V198, P3264, DOI 10.4049/jimmunol.1602106 | eng |
hcfmusp.relation.reference | Fernandes ML, 2010, BRAZ J MED BIOL RES, V43, P860, DOI 10.1590/S0100-879X2010000900008 | eng |
hcfmusp.relation.reference | Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824 | eng |
hcfmusp.relation.reference | Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603 | eng |
hcfmusp.relation.reference | Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC | eng |
hcfmusp.relation.reference | Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836 | eng |
hcfmusp.relation.reference | FREUDENBERG MA, 1986, INFECT IMMUN, V51, P891 | eng |
hcfmusp.relation.reference | Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329 | eng |
hcfmusp.relation.reference | Funk DJ, 2009, CRIT CARE CLIN, V25, P83, DOI 10.1016/j.ccc.2008.12.003 | eng |
hcfmusp.relation.reference | Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000 | eng |
hcfmusp.relation.reference | Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552 | eng |
hcfmusp.relation.reference | Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333 | eng |
hcfmusp.relation.reference | Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003 | eng |
hcfmusp.relation.reference | JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1 | eng |
hcfmusp.relation.reference | Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43 | eng |
hcfmusp.relation.reference | Kellum JA, 2018, NAT REV NEPHROL, V14, P217, DOI 10.1038/nrneph.2017.184 | eng |
hcfmusp.relation.reference | Lamontagne F, 2017, JAMA-J AM MED ASSOC, V317, P267, DOI 10.1001/jama.2016.19684 | eng |
hcfmusp.relation.reference | Levy Mitchell M, 2003, Intensive Care Med, V29, P530 | eng |
hcfmusp.relation.reference | Besen BAMP, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0204-y | eng |
hcfmusp.relation.reference | Machado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5 | eng |
hcfmusp.relation.reference | Machado Flavia Ribeiro, 2016, Rev. bras. ter. intensiva, V28, P361, DOI [10.5935/0103-507x.20160068, 10.5935/0103-507X.20160068] | eng |
hcfmusp.relation.reference | Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084 | eng |
hcfmusp.relation.reference | Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801 | eng |
hcfmusp.relation.reference | Mendes ME, 2011, IMMUNOBIOLOGY, V216, P285, DOI 10.1016/j.imbio.2010.07.008 | eng |
hcfmusp.relation.reference | Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68 | eng |
hcfmusp.relation.reference | Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8 | eng |
hcfmusp.relation.reference | MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493 | eng |
hcfmusp.relation.reference | Nucci LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172024 | eng |
hcfmusp.relation.reference | O'Gara JP, 2017, ENVIRON MICROBIOL, V19, P3823, DOI 10.1111/1462-2920.13833 | eng |
hcfmusp.relation.reference | O'Neill J, 2014, REV ANTIMICROBIAL RE | eng |
hcfmusp.relation.reference | O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70 | eng |
hcfmusp.relation.reference | Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194 | eng |
hcfmusp.relation.reference | Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332 | eng |
hcfmusp.relation.reference | Pacher P, 2002, BIOCHEM PHARMACOL, V64, P1785, DOI 10.1016/S0006-2952(02)01421-1 | eng |
hcfmusp.relation.reference | Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005 | eng |
hcfmusp.relation.reference | Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014 | eng |
hcfmusp.relation.reference | Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328 | eng |
hcfmusp.relation.reference | Rello J, 2016, INT J INFECT DIS, V48, P120, DOI 10.1016/j.ijid.2016.04.017 | eng |
hcfmusp.relation.reference | Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6 | eng |
hcfmusp.relation.reference | Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/01.SHK.0000054740.68620.c4 | eng |
hcfmusp.relation.reference | Rudd KE, 2018, JAMA-J AM MED ASSOC, V319, P2202, DOI 10.1001/jama.2018.6229 | eng |
hcfmusp.relation.reference | Salomao R, 2002, J ENDOTOXIN RES, V8, P371, DOI 10.1179/096805102125000704 | eng |
hcfmusp.relation.reference | Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf | eng |
hcfmusp.relation.reference | Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0 | eng |
hcfmusp.relation.reference | Santos Sidneia S, 2016, Intensive Care Med Exp, V4, P5, DOI 10.1186/s40635-016-0078-1 | eng |
hcfmusp.relation.reference | Santos SS, 2012, SHOCK, V38, P18, DOI 10.1097/SHK.0b013e318257114e | eng |
hcfmusp.relation.reference | Scicluna BP, 2017, LANCET RESP MED, V5, P816, DOI 10.1016/S2213-2600(17)30294-1 | eng |
hcfmusp.relation.reference | Serafim R, 2018, CHEST, V153, P646, DOI 10.1016/j.chest.2017.12.015 | eng |
hcfmusp.relation.reference | Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288 | eng |
hcfmusp.relation.reference | Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289 | eng |
hcfmusp.relation.reference | Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287 | eng |
hcfmusp.relation.reference | Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008 | eng |
hcfmusp.relation.reference | Szabo C, 2010, SHOCK, V34, P4, DOI 10.1097/SHK.0b013e3181e7e9ba | eng |
hcfmusp.relation.reference | Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986 | eng |
hcfmusp.relation.reference | Thomer L, 2016, ANNU REV PATHOL-MECH, V11, P343, DOI 10.1146/annurev-pathol-012615-044351 | eng |
hcfmusp.relation.reference | Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9 | eng |
hcfmusp.relation.reference | van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36 | eng |
hcfmusp.relation.reference | Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549 | eng |
hcfmusp.relation.reference | Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806 | eng |
hcfmusp.relation.reference | Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002 | eng |
hcfmusp.relation.reference | Williams NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00141 | eng |
hcfmusp.relation.reference | Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1678-4510 | |
hcfmusp.citation.scopus | 163 | |
hcfmusp.scopus.lastupdate | 2024-02-23 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - LIM/49 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_SALOMAO_Sepsis_evolving_concepts_and_challenges_2019.PDF | publishedVersion (English) | 1.3 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.